Journal Watch

Recently added publications

Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trial.
Author(s): Scolari F, Dallera N, Gesualdo L, Santoro D, Pani A, Santostefano M, Feriozzi S, Mani LY, Boscutti G, Messa P, Magistroni R, Quaglia M, Ponticelli C, Ravani P
Source: BMJ Open 2019 Dec 4;9(12):e029232
Publication date: 2019-12-4
IgA1 deposition may induce NLRP3 expression and macrophage transdifferentiation of podocyte in IgA nephropathy.
Author(s): Peng W, Pei GQ, Tang Y, Tan L, Qin W
Source: J Transl Med 2019 Dec 3;17(1):406
Publication date: 2019-12-3
Graft failure of IgA nephropathy in renal allografts following living donor transplantation: predictive factor analysis of 102 biopsies.
Author(s): Zhang J, Chen GD, Qiu J, Liu GC, Chen LZ, Fu K, Wu ZX
Source: BMC Nephrol 2019 Dec 3;20(1):446
Publication date: 2019-12-3
Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy.
Author(s): Zou H, Li Y, Xu G
Source: BMC Nephrol 2019 Dec 2;20(1):442
Publication date: 2019-12-2
Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous nephropathy: a meta-analysis.
Author(s): Dong D, Fan TT, Wang YY, Zhang L, Song L, Zhang L
Source: BMC Nephrol 2019 Dec 2;20(1):444
Publication date: 2019-12-2



European Reference Networks
ERKNet is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Commission.
For more information about the ERNs and the EU health strategy, please visit http://ec.europa.eu/health/ern